Cargando…
Molecular docking of potential SARS-CoV-2 papain-like protease inhibitors
SARS-CoV-2 papain-like protease is considered as an important potential target for anti-SARS-CoV-2 drug discovery due to its crucial roles in viral spread and innate immunity. Here, we have utilized an in silico molecular docking approach to identify the possible inhibitors of the SARS-CoV-2 papain-...
Autores principales: | Li, Daoqun, Luan, Junwen, Zhang, Leiliang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7698687/ https://www.ncbi.nlm.nih.gov/pubmed/33276953 http://dx.doi.org/10.1016/j.bbrc.2020.11.083 |
Ejemplares similares
-
In silico Exploration of Inhibitors for SARS-CoV-2's Papain-Like Protease
por: Huynh, Tien, et al.
Publicado: (2021) -
Supercomputing, Docking and Quantum Mechanics in Quest for Inhibitors of Papain-like Protease of SARS-CoV-2
por: Sulimov, A. V., et al.
Publicado: (2021) -
Identification of Papain-Like Protease inhibitors of SARS CoV-2 through HTVS, Molecular docking, MMGBSA and Molecular dynamics approach
por: Jupudi, Srikanth, et al.
Publicado: (2022) -
In silico analysis of SARS-CoV-2 papain-like protease potential inhibitors
por: Elseginy, Samia A., et al.
Publicado: (2021) -
Validation and Invalidation of SARS-CoV-2 Papain-like
Protease Inhibitors
por: Ma, Chunlong, et al.
Publicado: (2022)